These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30249615)

  • 21. Human Papillomavirus Vaccination.
    Markowitz LE; Unger ER
    N Engl J Med; 2023 May; 388(19):1790-1798. PubMed ID: 37163625
    [No Abstract]   [Full Text] [Related]  

  • 22. Media effect--Letter to the editor about the manuscript titled: increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine.
    Kim TH; Lee HH
    Arch Gynecol Obstet; 2014 Mar; 289(3):473-4. PubMed ID: 24318275
    [No Abstract]   [Full Text] [Related]  

  • 23. Response to: Media effect-letter to the editor about the manuscript titled Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine.
    Sotiriadis A; Dagklis T; Siamanta V; Chatzigeorgiou K; Agorastos T;
    Arch Gynecol Obstet; 2014 Mar; 289(3):475-6. PubMed ID: 24310411
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the articles published by Dr. Berndt regarding the HPV vaccination on 11/26/2008].
    Hofmann F; Heininger U
    Pharm Unserer Zeit; 2009; 38(2):190-1. PubMed ID: 19353818
    [No Abstract]   [Full Text] [Related]  

  • 25. Introducing human papillomavirus vaccines - questions remain.
    Paavonen J; Lehtinen M
    Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination against human papillomavirus.
    BMJ Group
    Drug Ther Bull; 2008 Dec; 46(12):89-93. PubMed ID: 19056700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV vaccination: Clinical potential, implementation challenges, and future directions.
    Perkins RB
    Hum Vaccin Immunother; 2016 Jun; 12(6):1327-31. PubMed ID: 27294609
    [No Abstract]   [Full Text] [Related]  

  • 29. How will HPV vaccines affect cervical cancer?
    Roden R; Wu TC
    Nat Rev Cancer; 2006 Oct; 6(10):753-63. PubMed ID: 16990853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme].
    de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2639-40; author reply 2640-1. PubMed ID: 19105259
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of lipoatrophy following quadrivalent human papillomavirus vaccine administration.
    Stéphan F; Korkomaz J; Abadjian G; Okais J; Tomb R
    J Am Acad Dermatol; 2014 Jun; 70(6):e132-4. PubMed ID: 24831333
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter to the editor referring to the manuscript entitled: "Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine" reported by Sotiriadis et al. (Arch Gynecol Obstet. 2012 Jun;285(6):1719-24).
    Chatzistamatiou K; Sotiriadis A; Agorastos T
    Arch Gynecol Obstet; 2014 Mar; 289(3):471-2. PubMed ID: 23959094
    [No Abstract]   [Full Text] [Related]  

  • 34. Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis.
    Akioka S
    Ann Rheum Dis; 2014 Dec; 73(12):e75. PubMed ID: 25165031
    [No Abstract]   [Full Text] [Related]  

  • 35. [Demyelinating disease and vaccination of the human papillomavirus].
    Álvarez-Soria MJ; Hernández-González A; Carrasco-García de León S; del Real-Francia MÁ; Gallardo-Alcañiz MJ; López-Gómez JL
    Rev Neurol; 2011 Apr; 52(8):472-6. PubMed ID: 21425100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of Human Papillomavirus Vaccines: An Updated Review.
    Phillips A; Patel C; Pillsbury A; Brotherton J; Macartney K
    Drug Saf; 2018 Apr; 41(4):329-346. PubMed ID: 29280070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
    Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ
    Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two HPV vaccines yielding similar success.
    Washam C
    J Natl Cancer Inst; 2005 Jul; 97(14):1030. PubMed ID: 16030297
    [No Abstract]   [Full Text] [Related]  

  • 40. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V; Murtagh J
    Issues Emerg Health Technol; 2007 Dec; (109):1-8. PubMed ID: 18062141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.